WuXi Biologics
WuXi Biologics is a global company that provides comprehensive, integrated and highly customizable services for the discovery, development and manufacturing of biologics. The company is headquartered in Wuxi, China, and has multiple facilities across China, Europe, and North America.
History[edit | edit source]
WuXi Biologics was founded in 2010 as a subsidiary of WuXi AppTec, a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform company. WuXi Biologics has since grown to become a separate entity, listed on the Hong Kong Stock Exchange in 2017.
Services[edit | edit source]
WuXi Biologics offers a range of services that span the entire biologics value chain, including biologics discovery, biologics development, and biologics manufacturing. The company's integrated service platform is designed to provide clients with a seamless, efficient, and cost-effective solution for bringing biologics from concept to market.
Discovery[edit | edit source]
In the discovery phase, WuXi Biologics provides services such as antibody discovery, protein engineering, and cell line development. The company utilizes advanced technologies and platforms, including its proprietary Open-CHO Cell Line platform, to accelerate the discovery process.
Development[edit | edit source]
In the development phase, WuXi Biologics offers services such as process development, analytical development, and formulation development. The company's development services are designed to optimize the production process and ensure the quality, safety, and efficacy of the biologic.
Manufacturing[edit | edit source]
In the manufacturing phase, WuXi Biologics provides services such as clinical manufacturing, commercial manufacturing, and fill/finish. The company's manufacturing facilities are equipped with state-of-the-art technologies and adhere to stringent Good Manufacturing Practices (GMP) standards.
Partnerships[edit | edit source]
WuXi Biologics has established partnerships with numerous pharmaceutical and biotechnology companies worldwide. These partnerships enable the company to leverage its capabilities and expertise to accelerate the development and commercialization of innovative biologics.
See also[edit | edit source]
- Biopharmaceutical
- Contract development and manufacturing organization
- Pharmaceutical industry in China
References[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
